Render Target: STATIC
Render Timestamp: 2024-12-20T12:21:23.386Z
Commit: f2d32940205a64f990b886d724ccee2c9935daff
XML generation date: 2024-09-20 06:22:01.230
Product last modified at: 2024-12-17T19:02:13.562Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

MAGE-A4 (E7O1U) XP® Rabbit mAb #82491

Filter:
  • WB
  • IHC
  • IF
  • F

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 40-50
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IHC-Immunohistochemistry 
    • IF-Immunofluorescence 
    • F-Flow Cytometry 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunohistochemistry (Paraffin) 1:100 - 1:400
    Immunofluorescence (Immunocytochemistry) 1:50 - 1:100
    Flow Cytometry (Fixed/Permeabilized) 1:200 - 1:800

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    For a carrier free (BSA and azide free) version of this product see product #31135.

    Protocol

    Specificity / Sensitivity

    MAGE-A4 (E7O1U) XP® Rabbit mAb recognizes endogenous levels of total MAGE-A4 protein. This antibody does not cross-react with MAGE-A2, A3, A6, A10, or A12 proteins.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ala 60 of human MAGE-A4 protein.

    Background

    Cancer/testis antigens (CTAs) are a family of more than 100 proteins whose normal expression is largely restricted to immune privileged germ cells of the testis, ovary, and trophoblast cells of the placenta. Although most normal somatic tissues are void of CTA expression, due to epigenetic silencing of gene expression, their expression is upregulated in a wide variety of human solid and liquid tumors (1,2). As such, CTAs have garnered much attention as attractive targets for a variety of immunotherapy-based approaches to selectively attack tumors (3).

    Melanoma-associated antigen-A4 (MAGE-A4) is a cancer testis antigen that belongs to the type I MAGE family of proteins. MAGE-A4 is often overexpressed and mutated in several types of cancer (4-8). Research shows MAGE-A4 promotes aberrant cell growth by preventing p53-dependent cell cycle arrest and apoptosis in normal oral keratinocytes (9). However, MAGE-A4 was also found to interact with the liver oncoprotein gankyrin, suppressing its tumorigenic activity (10). The diverse roles of MAGE-A4 in tumor development may be dependent upon sub-cellular localization (nuclear or cytosolic) and p53 status (6). Due to its upregulated expression in human tumors and high degree of immunogenicity, MAGE-A4 has received significant attention as an immunotherapy target through the use of vaccines and adoptive cell therapy (11-14).
    1. Caballero, O.L. and Chen, Y.T. (2009) Cancer Sci 100, 2014-21.
    2. De Smet, C. et al. (1999) Mol Cell Biol 19, 7327-35.
    3. Gjerstorff, M.F. et al. (2015) Oncotarget 6, 15772-87.
    4. Iura, K. et al. (2017) Virchows Arch 471, 383-92.
    5. Sani, S.A. et al. (2018) J Cancer Res Ther 14, 1059-64.
    6. Fujiwara-Kuroda, A. et al. (2018) Int J Oncol 53, 713-24.
    7. Iura, K. et al. (2017) Hum Pathol 61, 130-9.
    8. Caballero, O.L. et al. (2010) PLoS One 5(11):10.1371
    9. Caballero, O.L. et al. (2010) PLoS One 5, e12773. doi: 10.1371/journal.pone.0012773.
    10. Bhan, S. et al. (2012) Oncol Rep 28, 1498-502.
    11. Nagao, T. et al. (2003) J Biol Chem 278, 10668-74.
    12. Saito, T. et al. (2014) Vaccine 32, 5901-7.
    13. Kageyama, S. et al. (2015) Clin Cancer Res 21, 2268-77.
    14. Ueda, S. et al. (2018) Oncotarget 9, 35997-6011.
    15. Cruz, C.R. et al. (2011) Clin Cancer Res 17, 7058-66.
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    Alexa Fluor is a registered trademark of Life Technologies Corporation.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.